Patients in England Brace for Crackdown on Common Pain Medications
Patients in Europe have grown accustomed to health technology assessment bodies passing judgment on new medications. But in England recently the National Institute for Health and Care Excellence, or NICE, has taken the appraisal process one step too far.
Why Patients are Prepared to Fight for a Voice in the Value Debate
Empowering Patients in the Value Debate
Patients need a more meaningful role in decisions about the value of medications, a new report from the Global Alliance for Patient Access explains.
European Patient Groups Call for HTA Improvements
The COVID-19 pandemic has made one point clear for advocates: Health technology assessments across Europe could work better and more efficiently.
